CHRISTIE BALLANTYNE to Fibrinolytic Agents
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Fibrinolytic Agents.
Connection Strength
0.074
-
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study. Diabetes Obes Metab. 2023 06; 25(6):1750-1757.
Score: 0.047
-
Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21.
Score: 0.027